Table 5 Outcomes of cholecalciferol treatment in hospitalized COVID-19 patients with VDD, data presented as number (percentage) for categorical^a and mean (SD) for continuous variables^b.

Age (years)^b

45.5 (18.2)

48.8 (14.7)

Comorbidities^a

68 (53.1)

42 (60.9)

Severe cases^a

14 (10.9)

12 (17.4)

Mortality^a

1 (0.8)

3 (4.3)

ICU admission^a

16 (12.5)

13 (18.8)

Oxygen administration^a

38 (29.7)

30 (43.5)

CRP (mg/L)^b

71.2 (427.2)

46.2(64.8)

IL-6(pg/mL)^b

41.1 (122.5)

54.6 (97.7)

D-dimer (ng/mL)^b

392.7 (1396.3)

602.9 (2042.7)

Ferritin(ng/mL)^b

273.5 (355.3)

439.4 (914.5)

LDH (IU/L)^b

289.5 (109.8)

333.8 (159.4)